top of page
Neurovascular Health Management

Brain Care

Cerebrolysin IV

Powerful Free Radical Removal × Improved Circulation × Neuroprotection

Worried about free radical damage? Cerebrolysin IV Therapy can help.

Modern life—filled with stress and environmental pollution—often leads to excess free radicals in the body. These can damage blood vessels and nerves, and speed up aging.

Cerebrolysin IV Therapy uses a medical-grade formula to help prevent stroke, vascular hardening, and neurological decline. By clearing free radicals, improving blood flow, and reducing inflammation, it offers full-spectrum support for vascular and neurological wellness.

What is Cerebrolysin IV Therapy?

The key ingredient, Edaravone, is a potent free radical scavenger. Administered intravenously, it rapidly enters the bloodstream to exert antioxidant and anti-inflammatory effects, reducing cellular damage from free radicals and improving microcirculation, helping your body restore vitality.

Enlarge

Cerebrolysin IV Therapy
Cerebrolysin IV Therapy

Key Ingredients & Benefits

  • Antioxidant Defense | Reduces Oxidative Stress
    Edaravone rapidly neutralizes free radicals in blood and cells, protecting cell membranes, DNA, and proteins.
    Studies show it can reduce brain cell death by up to 30% and significantly aid neurological recovery after stroke.

  • Improves Microcirculation | Boosts Oxygen Supply
    The treatment reduces vascular inflammation, improves blood fluidity, and enhances oxygen and nutrient delivery—supporting recovery in oxygen-deprived tissues.

  • Reduces Inflammation | Protects Nerves & Vessels
    It inhibits inflammatory markers (e.g., IL-6, CRP), slowing damage to vascular and neural cells while supporting vascular elasticity and neural stability.

Who Is It For?

  • People with a history of ischemic stroke

  • Those diagnosed with vascular dementia

  • Individuals with neurological damage (e.g., traumatic brain or spinal injury)

  • People with poor nutrition or protein absorption issues

  • Adults seeking preventive neurovascular care

Cerebrolysin IV Therapy?
Cerebrolysin IV Therapy?
Cerebrolysin IV Therapy?

Frequently Asked Questions 

  • Cerebrolysin is an injectable formulation composed of low-molecular-weight amino acids and neurotrophic peptides, administered intravenously. Research indicates that its components can mimic the body’s natural neurotrophic factors, supporting and protecting neuronal function.

    • Stroke recovery patients, particularly if treatment starts within 72 hours of onset (recommended course: 10–21 days).

    • Vascular dementia patients (recommended multi-week course to enhance cognitive improvement).

    • Patients with increased protein requirements due to malnutrition or trauma.

    • Initial Phase: Daily administration, either intramuscularly or intravenously, typically 2 vials per session.

    • Maintenance Phase: Depending on patient condition, dosing may be adjusted to every other day or every 2–3 days.

    • Duration: Mild cases may require 10–15 sessions; moderate to severe cases may need extended treatment.

  • Clinical studies show that stroke and dementia patients experience functional improvements within the first four weeks of treatment, with statistically significant progress observed at 1–3 months.

    • Each session is administered as a diluted infusion, usually lasting 30–120 minutes.

    • Frequency is adjusted according to the treatment stage, starting daily and gradually extending intervals.

  • During administration, mild burning or warming sensations are common. Less frequently, patients may experience chills, low-grade fever, or headache. Overall, the therapy demonstrates a favorable safety profile.

    • Severe renal impairment (contraindicated).

    • Patients with epilepsy require careful assessment prior to use.

    • Maintain hydration and a stable diet the day before treatment.

    • Report any discomfort immediately during infusion.

    • Strict adherence to prescribed dosage and infusion rate is required.

    • Functional outcomes are evaluated using standardized tools (e.g., NIHSS, mRS).

    • Combining therapy with rehabilitation enhances effectiveness.

    • Regular follow-up is recommended to assess progress.

  • Cerebrolysin is a prescription medication primarily used as a neurotrophic support agent. It is not recommended for purely preventive or daily wellness purposes. Prior to use, a thorough evaluation should be conducted, and the treatment necessity should be determined by a licensed physician.

bottom of page